Tyra Biosciences, Inc. (TYRA)
TYRA moved a median of +0.16% 30 minutes after news, and +0.02% by the close. How TYRA actually reacts to news — the realized, point-in-time move the market made, measured across 371 labeled events over the last three years with zero look-ahead.
TYRA’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 38% | 360 |
| 30-min | +0.16% | 52% | 368 |
| 60-min | +0.13% | 53% | 368 |
| to close | +0.02% | 50% | 367 |
| Middle 50% of TYRA reactions | -1.48% to +1.69% |
|---|---|
| Median reaction (30-min) | +0.16% |
| Measured reactions | 371 |
Half of all Tyra Biosciences, Inc. news events land between -1.48% and +1.69% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How TYRA reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations | 34 | +0.26% | 53% | -1.52% |
| Rating reiterations | 68 | -0.92% | 35% | -0.14% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 4 further classes were observed with fewer than 10 measured events and are not published. See how TYRA ranks against every other measured name →
That’s how TYRA usually reacts — get an email when it moves on news →Email me when TYRA moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to TYRA's baseline. Nothing else.
Recent TYRA events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Bronstein, Gewirtz & Grossman (TYRA) And Encourages Stockholders to Connect | Press release | ACCESS Newswire | -0.27% | — | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Tyra Biosciences, Inc. (TYRA) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | -0.68% | -0.77% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Tyra Biosciences, Inc. (TYRA) And Encourages Shareholders to Reach Out | Press release | ACCESS Newswire | -0.02% | +0.69% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Tyra Biosciences, Inc. (TYRA) and Encourages Shareholders to Learn More About the Investigation | Press release | ACCESS Newswire | +0.00% | -0.37% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Tyra Biosciences, Inc. (TYRA) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | -0.14% | -0.96% | |
| Tyra Biosciences, Inc. (TYRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | -0.30% | +0.80% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Tyra Biosciences, Inc. (TYRA) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +1.82% | -1.50% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Tyra Biosciences, Inc. (TYRA) And Encourages Stockholders to Reach Out | Press release | ACCESS Newswire | -0.19% | +1.95% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Tyra Biosciences, Inc. (TYRA) And Encourages Stockholders to Connect | Press release | ACCESS Newswire | -0.39% | +0.04% | |
| Tyra Biosciences, Inc. (TYRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.16% | -3.68% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Tyra Biosciences, Inc. (TYRA) and Encourages Stockholders to Learn More About the Investigation | Press release | ACCESS Newswire | -0.16% | -0.39% | |
| Form 8-K Tyra Biosciences, Inc. For: Sep 14 | SEC filing · Form 8-K | SEC EDGAR | -0.69% | +2.91% | |
| Form S-3ASR Tyra Biosciences, Inc. | SEC filing · Form S-3ASR | SEC EDGAR | +2.33% | +8.06% | |
| Tyra Announces Pricing of $400 Million Underwritten Offering of Common Stock and Pre-Funded Warrants | Press release | PR Newswire | +2.33% | +8.06% | |
| Form 8-K Tyra Biosciences, Inc. For: Sep 09 | SEC filing · Form 8-K | SEC EDGAR | +4.42% | +17.32% | |
| Tyra Biosciences Reports Initial Phase 2 SURF302 Results Supporting the First Potential Oral Innovation in LG IR NMIBC with Dabogratinib | Press release | PR Newswire | +4.42% | +17.32% | |
| Tyra Biosciences to Present at the Cantor Global Healthcare Conference | Press release | PR Newswire | +4.42% | +17.32% | |
| Tyra Biosciences to Host Conference Call on Initial Results of Oral Dabogratinib from the SURF302 Phase 2 Study for IR NMIBC on September 9, 2026 | Press release | PR Newswire | +1.94% | +16.89% | |
| Form 10-Q Tyra Biosciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +1.69% | -11.35% | |
| Form 8-K Tyra Biosciences, Inc. For: Aug 04 | SEC filing · Form 8-K | SEC EDGAR | +1.69% | -11.35% | |
| Tyra Biosciences Reports Second Quarter 2026 Financial Results and Recent Highlights | Press release | PR Newswire | +1.69% | -11.35% | |
| Form 8-K Tyra Biosciences, Inc. For: May 28 | SEC filing · Form 8-K | SEC EDGAR | +0.75% | +0.63% | |
| TYRA BIOSCIENCES AND BCAN ESTABLISH MAY 21 AS UPPER TRACT UROTHELIAL CANCER (UTUC) AWARENESS DAY | Press release | PR Newswire | -0.39% | +0.09% | |
| Form 10-Q Tyra Biosciences, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +1.49% | +3.79% | |
| Form 8-K Tyra Biosciences, Inc. For: May 13 | SEC filing · Form 8-K | SEC EDGAR | +1.49% | +3.79% | |
| Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights | Press release | PR Newswire | +1.49% | +3.79% | |
| Tyra Biosciences to Participate in Upcoming Investor Conferences | Press release | PR Newswire | +1.03% | +4.16% | |
| Form 8-K Tyra Biosciences, Inc. For: Apr 16 | SEC filing · Form 8-K | SEC EDGAR | +2.39% | +0.03% | |
| Form ARS Tyra Biosciences, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +2.39% | +0.03% | |
| Form DEF 14A Tyra Biosciences, Inc. For: May 28 | SEC filing · Form DEF | SEC EDGAR | +2.39% | +0.03% | |
| Form DEFA14A Tyra Biosciences, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +2.39% | +0.03% | |
| Tyra Biosciences Announces Appointment of Habib Dable to its Board of Directors | Press release | PR Newswire | +2.39% | +0.03% | |
| Form 8-K Tyra Biosciences, Inc. For: Apr 01 | SEC filing · Form 8-K | SEC EDGAR | +0.68% | -1.74% | |
| Form 8-K Tyra Biosciences, Inc. For: Mar 04 | SEC filing · Form 8-K | SEC EDGAR | -1.78% | -0.14% | |
| Form 10-K Tyra Biosciences, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +2.06% | +5.13% | |
| Form 8-K Tyra Biosciences, Inc. For: Mar 02 | SEC filing · Form 8-K | SEC EDGAR | +2.06% | +5.13% | |
| Tyra Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights | Press release | PR Newswire | +2.06% | +5.13% | |
| Tyra Biosciences Announces Poster Presentations at the 2026 ASCO® Genitourinary (GU) Cancers Symposium | Press release | PR Newswire | -0.98% | -0.21% | |
| Tyra Biosciences to Participate in Upcoming Investor Conferences | Press release | PR Newswire | -1.42% | +1.54% | |
| Form 8-K Tyra Biosciences, Inc. For: Nov 25 | SEC filing · Form 8-K | SEC EDGAR | +2.37% | -0.34% | |
| Tyra Biosciences Strengthens Leadership Team with Appointments of Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer | Press release | PR Newswire | +2.37% | -0.34% | |
| Tyra Biosciences Announces Participation at Upcoming Investor Events | Press release | PR Newswire | +0.72% | — | |
| Form 10-Q Tyra Biosciences, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.14% | -3.06% | |
| Form 8-K Tyra Biosciences, Inc. For: Nov 05 | SEC filing · Form 8-K | SEC EDGAR | +0.14% | -3.06% | |
| Tyra Biosciences Reports Third Quarter 2025 Financial Results and Highlights | Press release | PR Newswire | +0.14% | -3.06% | |
| Form 8-K Tyra Biosciences, Inc. For: Aug 21 | SEC filing · Form 8-K | SEC EDGAR | +1.61% | -0.51% | |
| Tyra Biosciences Announces First Child Dosed in BEACH301, its Phase 2 Study for Dabogratinib (TYRA-300) in Pediatric Achondroplasia | Press release | PR Newswire | -1.48% | +15.50% | |
| Tyra Biosciences Announces Participation at Upcoming Investor Events | Press release | PR Newswire | -1.48% | +15.50% | |
| Form 10-Q Tyra Biosciences, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.04% | -4.62% | |
| Form 8-K Tyra Biosciences, Inc. For: Aug 14 | SEC filing · Form 8-K | SEC EDGAR | -0.04% | -4.62% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the TYRA section they belong to.
Where else TYRA is measured.
TYRA earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Tyra Biosciences, Inc.'s median reaction calculated?
Every labeled TYRA news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 371 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 52% of TYRA's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does TYRA's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.